QUOTED. Sarah Cummings.
Executive Summary
Federal recoveries from False Claims Act cases have been down during pandemic times – but the drop is likely to be far from permanent, Reed Smith partner Sarah Cummings said at a Food and Drug Law Institute conference.
“This is not the signal of any kind of slowdown. The telling factor is that even though recoveries were down, more new cases were filed than in any year since the FCA was enacted.” – Sarah Cummings, partner, Reed Smith
Click here for a free trial of Medtech Insight